(+/-)-8-PRENYLNARINGENIN
(+/-)-8-PRENYLNARINGENIN Basic information
- Product Name:
- (+/-)-8-PRENYLNARINGENIN
- Synonyms:
-
- (±)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-Methyl-2-butenyl)-4H-1-benzopyran-4-one
- 2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-Methyl-2-buten-1-yl)-4H-1-benzopyran-4-one
- rac 8-Prenylnaringenin
- 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methyl-2-buten-1-yl)-
- Naringenin 8-Prenyl Racemate
- (+/-)-8-PRENYLNARINGENIN
- (±)-8-Prenylnaringenin
- CAS:
- 68682-02-0
- MF:
- C20H20O5
- MW:
- 340.37
- EINECS:
- 245-096-7
- Product Categories:
-
- Aromatics
- Heterocycles
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Mol File:
- 68682-02-0.mol
(+/-)-8-PRENYLNARINGENIN Chemical Properties
- Melting point:
- 183-184 °C
- Boiling point:
- 597.6±50.0 °C(Predicted)
- Density
- 1.314±0.06 g/cm3(Predicted)
- storage temp.
- −20°C
- solubility
- DMSO (Slightly), Methanol (Slightly)
- form
- Light yellow powder
- pka
- 7.70±0.40(Predicted)
- color
- Off-White to Pale Yellow
- Stability:
- Light Sensitive
Safety Information
- Safety Statements
- 22-24/25
- WGK Germany
- 3
(+/-)-8-PRENYLNARINGENIN Usage And Synthesis
Description
(±)-8-Prenylnaringenin ((±)-8-PN) is a prenylflavonoid with potent estrogenic activity that can be isolated from hops. It inhibits both isoforms of the human estrogen receptor (ER; IC50s = 57 and 68 nM for ERα and ERβ, respectively). (±)-8-PN is effective in vivo, suppressing loss of bone mineral density in ovariectomized rats and blocking changes in tail skin temperature in a rat model of postmenopausal hot flashes.
Uses
8-Prenylnaringenin is a prenylflavonoid, a class on non-steroidal phytoestrogen that mimicks and/or modulating endogenous estrogens via estrogen receptor binding.
Definition
ChEBI: Rac 8-Prenylnaringenin is a member of flavanones.
in vivo
(±)-8-Prenylnaringenin (50 mg/kg; orally gavage; once daily; for 12 days) ameliorates impaired glucose homeostasis and islet dysfunction induced by STZ treatment. (±)-8-Prenylnaringenin increases the protein expression levels of ERα in the pancreas and liver and of fibroblast growth factor 21 in the liver[3].
| Animal Model: | Male C57BL/6J mice (Seven-week-old) injected with Streptozotocin (STZ)[3] |
| Dosage: | 50 mg/kg |
| Administration: | Orally gavage; once daily; for 12 days |
| Result: | Ameliorated impaired glucose homeostasis and islet dysfunction induced by STZ treatment. |
IC 50
ERα: 57 nM (IC50); ERβ: 68 nM (IC50)
References
[1] S. MILLIGAN. Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin.[J]. Reproduction, 2002, 123 2 1: 235-242. DOI: 10.1530/rep.0.1230235
[2] ATIEH HAJIRAHIMKHAN. Evaluation of estrogenic activity of licorice species in comparison with hops used in botanicals for menopausal symptoms.[J]. PLoS ONE, 2013: e67947. DOI: 10.1371/journal.pone.0067947
[3] FREDERIK ROELENS. Subtle Side-Chain Modifications of the Hop Phytoestrogen 8-Prenylnaringenin Result in Distinct Agonist/Antagonist Activity Profiles for Estrogen Receptors α and β[J]. Journal of Medicinal Chemistry, 2006, 49 25: 7357-7365. DOI: 10.1021/jm060692n
[4] ANNEKATHRIN M KEILER Georg K Oliver Zierau. Hop extracts and hop substances in treatment of menopausal complaints.[J]. Planta medica, 2013, 79 7: 576-579. DOI: 10.1055/s-0032-1328330
(+/-)-8-PRENYLNARINGENINSupplier
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 027-87465837 19945049750
- sales@finetechnology-ind.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com